Walleye Trading Advisors »

Lyell Immunopharma shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $446k 22k 20.06
2025-06-30 $258k 29k 8.84

More positions owned by Walleye Trading Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Apple (AAPL)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Airbnb Com Cl A (ABNB)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Applied Materials (AMAT)
Spotify Technology S A SHS (SPOT)
Johnson & Johnson (JNJ)

View all positions for Walleye Trading Advisors

Top funds holding Lyell Immunopharma

Arch Venture Corp
Vanguard Group
Foresite Capital Management IV
Orland Properties
Vanguard Capital Management
Almitas Capital
Foresite Capital Management V
Millennium Management
Citadel Advisors
venBio Partners
Alphabet
BlackRock
Geode Capital Management
Susquehanna International
Sc China Holding

View all funds holding Lyell Immunopharma